Google Chrome
Safari
Firefox
Edge
DDL 2024 - Drug Delivery to the Lungs Conference
Date:
2024/12/11
to 2024/12/13
Location:
Edinburgh, Scotland
Search
Webinar: High performance solutions for DPI delivery: new formulation and device platforms
Date:
2023/10/04
Location:
online
Devices
Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.
Press Clipping / May 11, 2026
Hovione and IDC announce new single-use capsule-based intranasal delivery device for dry powder formulations
OINDP - Orally inhaled and nasal drug products news, May 11, 2026
Press Clipping / May 07, 2026
Hovione, IDC Launch Intranasal Drug Delivery Platform
Contract Pharma, 7 May 2026
Sunriser® DPI
High Performance, High-Dose Capsule DPI.
Press Clipping / Jun 25, 2025
Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035
Pharmiweb.com, 25 June 2025
Press Clipping / May 03, 2023
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023